Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

SHA:600223 Revenue

Lushang Freda Pharmaceutical had revenue of 807.27M CNY in the quarter ending September 30, 2025, a decrease of -7.97%. This brings the company's revenue in the last twelve months to 3.78B, down -5.26% year-over-year. In the year 2024, Lushang Freda Pharmaceutical had annual revenue of 3.98B, down -13.02%.

• Revenue (ttm): 3.78B
• Revenue Growth: -5.26%
• P/S Ratio: 1.96
• Revenue / Employee: 1.04M
• Employees: 3,630
• Market Cap: 7.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.98B	-596.17M	-13.02%
Dec 31, 2023	4.58B	-8.37B	-64.65%
Dec 31, 2022	12.95B	588.17M	4.76%
Dec 31, 2021	12.36B	-1.25B	-9.20%
Dec 31, 2020	13.62B	3.33B	32.33%